Obliterative bronchiolitis
Obliterative bronchiolitis , also known as constrictive bronchiolitis and popcorn lung, is a disease that results in obstruction of the smallest airways of the lungs due to inflammation. Symptoms include a dry cough, shortness of breath, wheezing and feeling tired. These symptoms generally get worse over weeks to months. It is not related to cryptogenic organizing pneumonia, previously known as bronchiolitis obliterans organizing pneumonia.
Causes include breathing in toxic fumes, respiratory infections, connective tissue disorder or complications following a bone marrow or heart-lung transplant. Symptoms may not occur until two to eight weeks following toxic exposure or infection. The underlying mechanism involves inflammation that results in scar tissue formation. Diagnosis is by CT scan, pulmonary function tests or lung biopsy. A chest X-ray is often normal.
While the disease is not reversible, treatments can slow further worsening. This may include the use of corticosteroids or immunosuppressive medication. A lung transplant may be offered. Outcomes are often poor, with most people dying in months to years.
Obliterative bronchiolitis is rare in the general population. It, however, affects about 75% of people by ten years following a lung transplant and up to 10% of people who have received a bone marrow transplant from someone else. The condition was first clearly described in 1981. Prior descriptions occurred as early as 1956, with the term "bronchiolitis obliterans" used first by Reynaud in 1835.
Signs and symptoms
Obliterative bronchiolitis results in worsening shortness of breath, wheezing, and a dry cough. The symptoms can start gradually, or severe symptoms can occur suddenly. These symptoms represent an obstructive pattern that is non-reversible with bronchodilator therapy, and need to be related to various lung insults. These insults include inhalation damage, post transplant auto-immune injury, post-infectious disease, drug reactions, and several auto-immune diseases.Cause
Obliterative bronchiolitis has many possible causes, including collagen vascular disease, transplant rejection in organ transplant patients, viral infection, Stevens–Johnson syndrome, Pneumocystis pneumonia, drug reaction, aspiration and complications of prematurity, and exposure to toxic fumes, including diacetyl, sulfur dioxide, nitrogen dioxide, ammonia, chlorine, thionyl chloride, methyl isocyanate, hydrogen fluoride, hydrogen bromide, hydrogen chloride, hydrogen sulfide, phosgene, polyamide-amine dyes, mustard gas and ozone. It can also be present in patients with IBD, systemic lupus erythematosus, juvenile idiopathic arthritis, rheumatoid arthritis, GERD, IgA nephropathy, and ataxia telangiectasia. Activated charcoal, have been known to cause it when aspirated. The ingestion of large doses of papaverine in the vegetable Sauropus androgynus has caused it. Additionally, the disorder may be idiopathic.Lung transplant
Obliterative bronchiolitis is a common complication in lung transplant, because transplanted lungs are at greater risk of alloimmunization as compared to healthy lungs. The disease is often termed bronchiolitis obliterans syndrome in the setting of post lung transplantation and hematopoietic stem cell transplant. Patients who develop BOS post lung transplant vary in time frame and disease severity. Patients often initially have normal lung function on pulmonary function testing and have normal chest radiographs. As the disease progresses they begin to have symptoms of shortness of breath, cough, and wheezing as their lung function declines. The Journal of Heart and Lung Transplantation published updated guidelines in 2001 for grading the severity of BOS. The original guidelines and classification system were published in 1993 by the International Society for Heart and Lung Transplantation. Their scoring system is based on the changes in FEV1 in patients from their baseline. When patients are first diagnosed with BOS they have their baseline lung function established by doing pulmonary function testing at the time of diagnosis. The BOS scoring system is as follows:BOS 0: FEV1 > 90% of baseline and FEF25-75 > 75% of baseline
BOS 0-p: FEV1 81-89% of baseline and/or FEF25-75 <= 75% of baseline
BOS 1: FEV1 66-80% of baseline
BOS 2: FEV1 51-65% of baseline
BOS 3: FEV1 50% or less of baseline
The scoring system shows an increased severity of the disease as the BOS number increases.
Hematopoietic stem cell transplant
Obliterative bronchiolitis affects up to 5.5% of people who have received HSCT. One of the biggest risk factors after HSCT is the development of GVHD with a 14% risk. Other risk factors post transplant including tobacco use, age of donor, age of recipient, lower baseline FEV1/FVC ratio, non-caucasian race, peripheral and lower circulating IgG levels. Studies have, however, shown mixed results regarding these other risk factors. There has been an association shown between the increased use of peripheral stem cells and the risk of developing obliterative bronchiolitis. Also, research has shown an increased risk for developing the disease within the first year of transplant if the person is infected with respiratory syncytial virus or parainfluenza virus within the first 100 days post transplant.Inhalants
There are many industrial inhalants that are known to cause various types of bronchiolitis, including obliterative bronchiolitis.Industrial workers who have presented with bronchiolitis:
- nylon-flock workers
- workers who spray prints onto textiles with polyamide-amine dyes
- battery workers who are exposed to thionyl chloride fumes
- workers at plants that use or manufacture flavorings such as diacetyl
Post-infectious
Typically found in young children and is the most common cause at this age. Generally occurs after a viral infection of adenovirus, measles, mycoplasma, CMV, influenza, and parainfluenza. Swyer-James syndrome is a rare complication of obliterative bronchiolitis caused by measles or adenovirus. Post-infectious obliterative bronchiolitis is most common in the southern hemisphere particularly in countries such as Brazil, Argentina, Australia, Chile and New Zealand. There was a large prevalence of the disease in these areas during the 1990s and early 2000s. In one hospital in Buenos Aires, the Ricardo Gutiérrez Children's hospital, the disease accounted for 14% of their inpatient respiratory population from 1993 to 2002. As such, much of the information about post-infectious obliterative bronchiolitis has come from research out of South America. The most significant risk factors for the disease are infection with adenovirus and the need for ventilator support. In contrast with another cause of obliterative bronchiolitis in children, Steven's Johnson's syndrome, post-infectious obliterative bronchiolitis tends to be a chronic but non-progressive disease. The disease can have varying impact on children and their quality of life, which has been studied by lung function tests, as well as their exercise tolerance. Children with lower lung function based on their pulmonary function testing, have lower exercise tolerance, which compounds the impact of the disease on cardiovascular function as they are not able to maintain age appropriate aerobic fitness. This ultimately affects their activities of daily living and their quality of life going forward.Burn pits
A form of constrictive bronchiolitis is starting to present in Iraq and Afghanistan veterans. It has been attributed to veterans being exposed to trash burn pits. Veterans present with shortness of breath and other asthma-like symptoms. The only way to diagnose this condition is by doing a lung biopsy as chest X-rays and CT scans come back as normal. The government still denies that there is any correlation between burn pits and health problems but the government has started an "Airborne Hazards and Open Burn Pit Registry" to begin tracking the health of veterans who were exposed to burn pits to see if there is a connection.E-cigarettes
The American Lung Association lists flavored e-cigarettes as a risk in 2016. Health Canada has, however seen no cases as of 2019. Public Health England writes that the association has come about as "some flavourings used in e-liquids to provide a buttery flavour contain the chemical diacetyl... however, diacetyl is banned as an ingredient from e-cigarettes and e-liquids in the UK."Mechanism
The underlying mechanism involves injury and inflammation of epithelial and sub-epithelial cells. These cells then lose the ability to repair the tissue, in particular they lose the ability to regenerate the epithelial or outermost layer, leading to the excess growth of cells that cause scarring. There are multiple pathways of the disease including fibrotic, lymphocytic, and antibody-mediated that have been described. However, while each pathway has a more unique starting point and cause, the end result is still injury and inflammation leading to scarring of the lung tissue. The scarred tissue then makes the expiration phase of respiration more difficult, leading to air not being expelled from the lungs. This is termed "air-trapping", which can be seen on medical imaging. Since the scarring is non-reversible, the disease generally does not improve over time, and depending on the inciting can progress to death.Diagnosis
Obliterative bronchiolitis is often diagnosed based on the symptoms of obstructive lung disease following lung injury. The definitive diagnosis is through biopsy, but due to the variable distribution of lesions, leading to falsely negative tests, and invasive nature of this procedure it is often not performed. Several tests are often needed to diagnose obliterative bronchiolitis, including spirometry, diffusing capacity of the lung tests, lung volume tests, chest X-rays, high-resolution CT, and lung biopsy.Pulmonary function testing
Spirometry tests usually show an obstructive pattern and is the most common presentation. A slightly reduced to normal forced vital capacity, and a reduced FEV1 to FVC ratio and forced expiratory volume with little to no correction with the use of bronchodialators are common findings. Lung volume tests may show hyperinflation. Diffusing capacity of the lung tests are usually normal; people with early-stage OB are more likely to have normal DLCO.FEV1 should be above 80% of predicted values to be considered normal. Obliterative bronchiolitis reduces this to between 16% and 21%.
Medical imaging
Early in the disease chest radiography is typically normal but may show hyperinflation. As the disease progresses a reticular pattern with thickening of airway walls may be present. HRCT can also show air trapping when the person being scanned breathes out completely; it can also show thickening in the airway and haziness in the lungs. A common finding on HRCT is patchy areas of decreased lung density, signifying reduced vascular caliber and air trapping. This pattern is often described as a "mosaic pattern", and may indicate obliterative bronchiolitis.Lung biopsy
Transthoracic lung biopsies are preferable for diagnosis of constrictive BO compared to transbronchial biopsies; regardless of the type of biopsy, a diagnosis may only be achieved by examination of multiple samples. Transthoracic biopsies are preferred over transbronchial due to the heterogeneity and distribution of the lesions. OB can be further classified into two categories: constrictive or proliferative. The constrictive pattern is demonstrated by peribronchiolar cellular infiltrates which eventually causes small airway damage and leads to subepithelial fibrosis. The bronchial muscle can eventually become fibrosed which can be identified with trichrome staining. In regards to proliferative disease, intraluminal buds called "Masson bodies" fill the lumen, which results in bronchiolar plugging. Often people with proliferative disease will show butterfly wing-like appearance under microscopy. One key determinate that can be seen on biopsy to differentiate constrictive from proliferative disease is the extent of lesions. Both lesions are localized from the small bronchi to the membranous bronchi, but in constrictive disease the lesions are intermittent while proliferative disease has a continuous distribution.Differential diagnosis
Other conditions that can present similarly include chronic obstructive pulmonary disease, asthma, bronchiectasis, hypersensitivity pneumonitis, and pneumonia.Prevention
Inhalants
Disease caused by exposure to industrial inhalants and burn pits can be prevented with the use of engineering controls, personal protective equipment, monitoring of potentially affected personnel, worker education and training.Transplant
The primary prevention of obliterative bronchiolitis in people who have received either lung transplant or HSCT therapy is immunosuppression. In regards to post lung transplantion, the combination of calcineurin inhibitor combined with a purine synethesis inhibitor and a glucocorticoid is the general regimen used. People also have a baseline post-transplant lung function testing done in order to determine over time if their lung function is declining. People who are post HSCT their immunosuppressive regimen typically includes methotrexate in combination with a calcineurin inhibitor to prevent GVHD, a risk factor for developing obliterative bronchiolitis.Treatment
While the disease is not reversible, treatments can slow further worsening. This may include the use of corticosteroids or immunosuppressive medication which may have an effect on the ability to receive a lung transplant if offered. If patients have difficulty breathing oxygen can be supplemented. Routine vaccinations are recommended for patients with chronic lung disease to prevent complications from secondary infections due to pneumonia and influenza.Transplant recipients are at risk for re-developing the disease, as obliterative bronchiolitis is a form of chronic rejection. Evaluation of interventions to prevent obliterative bronchiolitis relies on early detection of abnormal spirometry results or unusual decreases in repeated measurements.
Terminology
"Bronchiolitis obliterans" was originally a term used by pathologist to describe two patterns of airway disease. One was bronchiolitis obliterans organizing pneumonia, also known as cryptogenic pneumonia, and the other is now known as obliterative bronchiolitis. The name cryptogenic obliterative bronchiolitis is used when a cause is unknown.Obliterative bronchiolitis is also not to be confused with bronchiolitis obliterans syndrome. BOS is defined as a person who has had either a HSCT or lung transplant and develops symptoms or radiographic findings consistent with bronchiolitis obliterans, but has not been confirmed by biopsy.